ABBOTT RAPID DX NORTH supplier risk profile Q1-2026: China-focused diagnostics imports, low compliance risk.
ABBOTT RAPID DX NORTH imported 87 shipments in Q1 2026 across three suppliers and three countries. China accounted for approximately 60% of shipments, with ABON BIOPHARM HANGZHOU as the leading supplier at 52 shipments. All imports fell under HS Chapter 38 (Miscellaneous chemical products), with secondary suppliers in Norway and Malta providing 23 and 10 shipments respectively.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer registered zero sanctions watchlist matches and zero suppliers with forced-labor exposure flagging in Q1 2026. No compliance red flags were identified in the supplier network review.
3 distinct tier-1 suppliers in Q1 2026
| ABON BIOPHARM HANGZHOU | China | 52 |
| ABBOTT DIAGNOSTICS TECHNOLOGIES | Norway | 23 |
| ABBOTT RAPID DIAGNOSTICS INTERNATIO | Malta | 10 |
Share of Q1 2026 inbound shipments by source country
3 tier-2 + 7 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.